Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients.

ABSTRACT:

Background

Medicinal cannabis (MC) is an increasingly utilized treatment option for various refractory diseases. While robust clinical evidence supporting MC efficacy in inflammatory bowel disease (IBD) is lacking, many IBD patients report using MC to obtain symptomatic relief. Understanding this use and associated outcomes may help inform future clinical trials.

Methods

A cross-sectional anonymous online survey was conducted involving Australians with IBD. It examined attitudes and experiences with MC in relation to IBD management. The survey included validated sub-questionnaires assessing quality of life, medication adherence, IBD severity, and functional impairment.

Results

A total of 838 responses were obtained. Results showed 25.3% (n = 212) of respondents were c

SUBMITTER: Benson MJ 

PROVIDER: S-EPMC9802391 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature